跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 30 条关于
“Aditams”
全部
30
临床试验
6
药物
12
机构
2
资讯
10
去年
Hanmi's Gugutams Launches in Mexico as Aditams: First Dual OPG-ED Combination Therapy Enters Latin American Market
3年前
Editas Medicine Advances EDIT-301 for Sickle Cell Disease and Beta Thalassemia, Prioritizes In Vivo Gene Editing
去年
Editas Medicine's Reni-Cel Shows Promise in Sickle Cell Disease Treatment
去年
Editas Medicine Achieves In Vivo Gene Editing Milestones, Plans Clinical Push
去年
Resiniferatoxin Receives FDA Breakthrough Therapy Designation for Osteoarthritis Pain
去年
Federal Circuit Remands CRISPR Patent Dispute to PTAB in Ongoing Editas Medicine Case
去年
Adams Clinical Expands into Inpatient Psychiatry and Schizophrenia Trials via InSite Partnership
6天前
Editas Medicine Targets 2026 Patient Dosing for In Vivo CRISPR LDL Therapy EDIT-401
去年
Editas Medicine Achieves 90% LDL Cholesterol Reduction with EDIT-401 Gene Therapy in Preclinical Studies
去年
Mabwell and Aditum Bio Launch Kalexo Bio to Advance Novel siRNA Therapy for Cardiovascular Disease